Subscribe for the newsletter
Sign in
Articles
Expert Interviews
Roundtable
Press Releases
Videos
The Road To Series
Market Research
Directory
More
Discovery
Small Molecules
Biologics
Advanced Therapies
Manufacturing
Supply Chain
Clinical Trials
Technologies
Financing
Press Releases
Sort By
Newest First
1 / 156
IFF
Nitrosamine
IFF Pharma Solutions Launches Low Nitrite METHOCEL™ HPMC for Nitrosamine Mitigation
IFF
PR-04-25-NI-01
Apr 08, 2025
National Academies of Sciences, Engineering, and Medicine
Open Letter
Public Statement on Supporting Science for the Benefit of All Citizens
National Academies of Sciences, Engineering, and Medicine
PR-03-25-NI-08
Mar 31, 2025
BioDuro
HPAPI
BioDuro Opens Shanghai Laboratory for Highly Potent Compound Synthesis
BioDuro
PR-03-25-NI-07
Mar 25, 2025
Verista
Tray Inspection
Verista to Showcase COUNTQ® Tray Inspection Systems at INTERPHEX 2025
Verista
PR-03-25-NI-06
Mar 24, 2025
Gannet BioChem
Appointment
Gannet BioChem Names Nicholas Shackley as Chief Executive Officer, Announces Leadership Team Expansion
Gannet BioChem
PR-03-25-NI-05
Mar 11, 2025
Vetter Pharma International GmbH
Expansion
Vetter Boosts Pharmaceutical Storage Capacity with Major Warehouse Expansion
Vetter Pharma International GmbH
PR-03-25-NI-04
Mar 11, 2025
Amgen
Dermatitis
Amgen and Kyowa Kirin Provide Top-Line Results From Rocatinlimab Phase 3 IGNITE Study in Atopic Dermatitits
Amgen
PR-03-25-NI-03
Mar 10, 2025
Moleculin Biotech, Inc.
Conference
Moleculin to Present at the 37th Annual ROTH Conference
Moleculin Biotech, Inc.
PR-03-25-NI-02
Mar 10, 2025
Bio-Techne Corporation
Western Blot
Bio-Techne Begins Shipping Leo - A Next Generation High-Throughput Simple Western System
Bio-Techne Corporation
PR-03-25-NI-01
Mar 10, 2025
Frontier Scientific Solutions
Appointment
Frontier Scientific Solutions Appoints Kevin Nash as President of European Operations
Frontier Scientific Solutions
PR-02-25-NI-22
Feb 25, 2025
Ultima Genomics
Financing
Ultima Genomics Increases Output by Over 50% and Lowers Sequencing Costs by a Further 20% with the Introduction of UG 100 Solaris™
Ultima Genomics
PR-02-25-NI-26
Feb 25, 2025
LabCorp
Announcement
Labcorp Announces Clinical Availability of Liquid Biopsy Test to Guide Personalized Treatment Plans
LabCorp
PR-02-25-NI-24
Feb 25, 2025
Vanda Pharmaceuticals
Announcement
Vanda Pharmaceuticals Announces the Publication of an Article "Personalized Treatment for Charcot-Marie-Tooth Disease Type 2S"
Vanda Pharmaceuticals
PR-02-25-NI-25
Feb 24, 2025
Kinvard Bio
Antibiotics
Kineticos Launches Kinvard Bio to Advance Next-Generation Antibiotics in the Fight Against Antimicrobial Resistance
Kinvard Bio
PR-02-25-NI-27
Feb 24, 2025
Cellex Cell Professionals
Announcement
Swarm Oncology and Cellex Cell Professionals Announce Partnership to Advance Swarm's T Cell Therapies for Solid Cancers
Cellex Cell Professionals
PR-02-25-NI-23
Feb 24, 2025
Boehringer Ingelheim Pharmaceuticals, Inc.
FDA
Boehringer's Zongertinib ReceivesFDA Priority Review for the Treatment of HER2 (ERBB2)- NSCLC
Boehringer Ingelheim Pharmaceuticals, Inc.
PR-02-25-NI-21
Feb 20, 2025
AccessDx Laboratory
Announcement
AccessDx Laboratory Announces Integration with PointClickCare
AccessDx Laboratory
PR-02-25-NI-20
Feb 19, 2025
Clarity Pharmaceuticals
Cu-67 SAR-bisPSMA
Clarity Receives US FDA Fast Track Designation for Treating Metastatic Castration-Resistant Prostate Cancer with Cu-67 SAR-bisPSMA
Clarity Pharmaceuticals
PR-02-25-NI-19
Feb 19, 2025
YourBio Health
Management
YourBio Health Strengthens Leadership Team to Propel Next Phase of Growth
YourBio Health
PR-02-25-NI-18
Feb 19, 2025
Bio-Techne Corporation
Announcement
Bio-Techne Announces Release of GMP TcBuster Non-Viral Genome Engineering System
Bio-Techne Corporation
PR-02-25-NI-17
Feb 19, 2025
1 / 156
